3 unknown, 1 completed, 1 recruiting, 1 terminated. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 3, Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging [18F]FAPI-74, 18F-FAPI-74 PET/CT Imaging - Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation | Phase 3 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 210 | 2026-09-18 | 2026-10-26 |
| Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Aminoglycosides intervention, Lack of protective isolation intervention, No systematic aminoglycosides intervention - standard arm - Sepsis, Septic Shock | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 340 | 2022-09-01 | 2022-07-05 |
| Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation Valganciclovir, Ganciclovir - Allogeneic Stem Cell Transplantation | Phase 3 | Terminated | Pierrel Research Europe GmbH | 212 | 2010-09-01 | 2012-12-10 |
| Exercise During the Allogeneic Stem Cell Transplantation Supervised exercise, Exercise Instruction - Fatigue, Allogeneic Stem Cell Transplantation | Phase 3 | Unknown | Charite University, Berlin, Germany | 60 | 2009-05-01 | 2009-12-23 |
| Multimodal Intervention in Allogeneic Stem Cell Transplantation Multimodal exercise and psychosocial program - Allogeneic Stem Cell Transplantation, Leukemia | Phase 3 | Completed | Copenhagen University Hospital, Rigshospitalet | 42 | 2005-08-01 | 2008-05-21 |
| Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT) Levofloxacin - Malignancy, Allogeneic Stem Cell Transplantation | Phase 2 / Phase 3 | Unknown | Charite University, Berlin, Germany | 2007-11-30 |
Neoplasms (3) · Acute Lung Injury (1) · Cardiovascular Diseases (1) · Fatigue (1) · Hematologic Neoplasms (1) · Leukemia (1) · Lung Diseases, Interstitial (1) · Motor Activity (1) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1) · Pulmonary Arterial Hypertension (1) · Sepsis (1) · Shock, Septic (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Amino Acid Metabolism, Inborn Errors (1) · Behavior (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hypertension, Pulmonary (1) · Infections (1) · Inflammation (1) · Lung Diseases (1) · Lung Injury (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Mitochondrial Diseases (1)
Ganciclovir (1) · Levofloxacin (1) · Valganciclovir (1)
Charite University, Berlin, Germany (2) · Assistance Publique - Hôpitaux de Paris (1) · Copenhagen University Hospital, Rigshospitalet (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Pierrel Research Europe GmbH (1)
Germany (3) · Austria (1) · Denmark (1) · Spain (1) · United States (1)
Anthony F Suffredini, M.D. (1) · Fernando Dimeo, MD (1) · Hermann Einsele, Prof. Dr. (1) · Igor Wolfgang Blau, Dr. (1) · Lis Adamsen, ProfessorPhD (1) · Mary E Jarden, MSN PhD stud (1)